header

Publications

« 2002 »

  • Nitric oxide and angiogenic activity of endothelial cells: direct or VEGF-dependent effect?
    Dulak J, Jozkowicz A.
    Cardiovasc Res. 2002 Dec;56(3):487-8; author reply 489-91.
    PMID: 12445890
  • Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1.
    Jozkowicz A, Huk I, Nigisch A, Weigel G, Weidinger F, Dulak J.
    Antioxid Redox Signal. 2002 Aug;4(4):577-85.
    PMID: 12230869
  • Vascular endothelial growth factor (VEGF) in ankylosing spondylitis--a pilot study.
    Goldberger C, Dulak J, Duftner C, Weidinger F, Falkenbach A, Schirmer M.
    Wien Med Wochenschr. 2002;152(9-10):223-5.
    PMID: 12094393
  • Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease.
    Alber HF, Dulak J, Frick M, Dichtl W, Schwarzacher SP, Pachinger O, Weidinger F.
    J Am Coll Cardiol. 2002 Jun 19;39(12):1951-5.
    PMID: 12084593
  • Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells.
    Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, Motterlini R.
    Antioxid Redox Signal. 2002 Apr;4(2):229-40.
    PMID: 12006174

Copyright © 2024 Department of Medical Biotechnology. All rights reserved.

Jagiellonian University Faculty of Biochemistry, Biophysics and Biotechnology Department of Medical Biotechnology